4.5 Review

Thymus, innate immunity and autoimmune arthritis: Interplay of gene and environment

期刊

FEBS LETTERS
卷 585, 期 23, 页码 3633-3639

出版社

WILEY
DOI: 10.1016/j.febslet.2011.10.026

关键词

Animal model; Autoimmune arthritis; Rheumatoid arthritis; ZAP-70; T cell selection; TCR signaling; Regulatory T cell; Innate immunity

资金

  1. Ministry of Education, Science, Sports and Culture, Japan
  2. Grants-in-Aid for Scientific Research [11J03737] Funding Source: KAKEN

向作者/读者索取更多资源

A hypomorphic mutation of the gene encoding zeta-associated protein-70 (ZAP-70), a signaling molecule in T cells, produces autoimmune arthritis in mice under a microbially conventional condition but not in a clean environment. The genetic anomaly alters thymic selection of self-reactive T cells as well as natural regulatory T cells and their respective functions. Highly self-reactive polyclonal T cells, including arthritogenic ones, thus produced by the thymus strongly recognize self-antigens presented by antigen-presenting cells, stimulate them to up-regulate co-stimulatory molecules and secrete cytokines that drive naive self-reactive T cells to differentiate into autoimmune effector Th17 cells. Administration of microbial products and activation of complement can facilitate the differentiation, evoking clinically overt arthritis in a microbially clean environment. Furthermore, mutation-dependent graded attenuation of T cell receptor signaling alters disease phenotypes and the dependency of disease occurrence on the environment. These findings provide a model of how genetic and environmental factors, in association, cause autoimmune diseases such as rheumatoid arthritis. (C) 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Autoimmune Th17 Cells Induced Synovial Stromal and Innate Lymphoid Cell Secretion of the Cytokine GM-CSF to Initiate and Augment Autoimmune Arthritis

Keiji Hirota, Motomu Hashimoto, Yoshinaga Ito, Mayumi Matsuura, Hiromu Ito, Masao Tanaka, Hitomi Watanabe, Gen Kondoh, Atsushi Tanaka, Keiko Yasuda, Manfred Kopf, Alexandre J. Potocnik, Brigitta Stockinger, Noriko Sakaguchi, Shimon Sakaguchi

IMMUNITY (2018)

Article Multidisciplinary Sciences

Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunity

Lucas Ferrari de Andrade, Rong En Tay, Deng Pan, Adrienne M. Luoma, Yoshinaga Ito, Soumya Badrinath, Daphne Tsoucas, Bettina Franz, Kenneth F. May, Christopher J. Harvey, Sebastian Kobold, Jason W. Pyrdol, Charles Yoon, Guo-Cheng Yuan, F. Stephen Hodi, Glenn Dranoff, Kai W. Wucherpfennig

SCIENCE (2018)

Article Immunology

Rapid CLIP dissociation from MHC II promotes an unusual antigen presentation pathway in autoimmunity

Yoshinaga Ito, Orr Ashenberg, Jason Pyrdol, Adrienne M. Luoma, Orit Rozenblatt-Rosen, Matan Hofree, Elena Christian, Lucas Ferrari de Andrade, Rong En Tay, Luc Teyton, Aviv Regev, Stephanie K. Dougan, Kai W. Wucherpfennig

JOURNAL OF EXPERIMENTAL MEDICINE (2018)

Article Multidisciplinary Sciences

Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody

Danbee Ha, Atsushi Tanaka, Tatsuya Kibayashi, Atsushi Tanemura, Daisuke Sugiyama, James Badger Wing, Ee Lyn Lim, Karen Wei Weng Teng, Dennis Adeegbe, Evan W. Newell, Ichiro Katayama, Hiroyoshi Nishikawa, Shimon Sakaguchi

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Immunology

Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer

James B. Wing, Atsushi Tanaka, Shimon Sakaguchi

IMMUNITY (2019)

Article Multidisciplinary Sciences

PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer

Takahiro Kamada, Yosuke Togashi, Christopher Tay, Danbee Ha, Akinori Sasaki, Yoshiaki Nakamura, Eiichi Sato, Shota Fukuoka, Yasuko Tada, Atsushi Tanaka, Hiromasa Morikawa, Akihito Kawazoe, Takahiro Kinoshita, Kohei Shitara, Shimon Sakaguchi, Hiroyoshi Nishikawa

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Immunology

Targeting Treg cells in cancer immunotherapy

Atsushi Tanaka, Shimon Sakaguchi

EUROPEAN JOURNAL OF IMMUNOLOGY (2019)

Article Immunology

Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells

Atsushi Tanaka, Hiroyoshi Nishikawa, Shinsuke Noguchi, Daisuke Sugiyama, Hiromasa Morikawa, Yoshiko Takeuchi, Danbee Ha, Naoya Shigeta, Toshio Kitawaki, Yuka Maeda, Takuro Saito, Yoshinori Shinohara, Yoshihiro Kameoka, Keiko Iwaisako, Fumihiko Monma, Kohshi Ohishi, Julia Karbach, Elke Jaeger, Kenichi Sawada, Naoyuki Katayama, Naoto Takahashi, Shimon Sakaguchi

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Review Immunology

Regulatory T Cells and Human Disease

Shimon Sakaguchi, Norihisa Mikami, James B. Wing, Atsushi Tanaka, Kenji Ichiyama, Naganari Ohkura

ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)

Article Immunology

Regulatory T Cell-Specific Epigenomic Region Variants Are a Key Determinant of Susceptibility to Common Autoimmune Diseases

Naganari Ohkura, Yoshiaki Yasumizu, Yohko Kitagawa, Atsushi Tanaka, Yamami Nakamura, Daisuke Motooka, Shota Nakamura, Yukinori Okada, Shimon Sakaguchi

IMMUNITY (2020)

Article Immunology

Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells

Rong En Tay, Olamide Olawoyin, Paloma Cejas, Yingtian Xie, Clifford A. Meyer, Qing Yu Weng, David E. Fisher, Henry W. Long, Myles Brown, Hye-Jung Kim, Kai W. Wucherpfennig

JOURNAL OF EXPERIMENTAL MEDICINE (2020)

Article Immunology

Dynamics of effector and naive Regulatory T cells throughout pregnancy

Naoya Shigeta, Keiichi Kumasawa, Atsushi Tanaka, James Badger Wing, Hitomi Nakamura, Shimon Sakaguchi, Tadashi Kimura

JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory

Yujiro Kidani, Wataru Nogami, Yoshiaki Yasumizu, Atsunari Kawashima, Atsushi Tanaka, Yudai Sonoda, Yumi Tona, Kunitaka Nashiki, Reimi Matsumoto, Masaki Hagiwara, Motonao Osaki, Keiji Dohi, Takayuki Kanazawa, Azumi Ueyama, Mai Yoshikawa, Tetsuya Yoshida, Mitsunobu Matsumoto, Kanji Hojo, Satomi Shinonome, Hiroshi Yoshida, Michinari Hirata, Miya Haruna, Yamami Nakamura, Daisuke Motooka, Daisuke Okuzaki, Yasuko Sugiyama, Makoto Kinoshita, Tatsusada Okuno, Taigo Kato, Koji Hatano, Motohide Uemura, Ryoichi Imamura, Kazunori Yokoi, Atsushi Tanemura, Yasushi Shintani, Tadashi Kimura, Norio Nonomura, Hisashi Wada, Masaki Mori, Yuichiro Doki, Naganari Ohkura, Shimon Sakaguchi

Summary: Specific removal of clonally expanding Tregs in tumor tissues for a limited period by cell-depleting anti-CCR8 mAb treatment can generate potent tumor immunity without causing deleterious autoimmunity. This approach can induce memory-type tumor-specific effector T cells while avoiding severe autoimmune diseases, resulting in long-lasting tumor immunity.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Immunology

Construction of a T cell receptor signaling range for spontaneous development of autoimmune disease

Atsushi Tanaka, Shinji Maeda, Takashi Nomura, Mara Anais Llamas-Covarrubias, Satoshi Tanaka, Lin Jin, Ee Lyn Lim, Hiromasa Morikawa, Yohko Kitagawa, Shuji Akizuki, Yoshinaga Ito, Chihiro Fujimori, Keiji Hirota, Tosei Murase, Motomu Hashimoto, Junichi Higo, Rose Zamoyska, Ryuzo Ueda, Daron M. M. Standley, Noriko Sakaguchi, Shimon Sakaguchi

Summary: This study investigates the relationship between aberrant TCR signaling and autoimmune disease, and provides a model to explain how altered TCR signaling triggers autoimmune diseases. The study found that reducing the expression of the ZAP-70 molecule to a critical range leads to the generation of autoimmune T cells and impairs the function of regulatory T cells, ultimately resulting in the occurrence of autoimmune/inflammatory diseases.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Oncology

Addressing TumorHeterogeneity by Sensitizing Resistant Cancer Cells to T cell-Secreted Cytokines

Yoshinaga Ito, Deng Pan, Wubing Zhang, Xixi Zhang, Tiffany Y. Juan, Jason W. Pyrdol, Oleksandr Kyrysyuk, John G. Doench, X. Shirley Liu, Kai W. Wucherpfennig

Summary: Tumor heterogeneity is a major obstacle in cancer therapy, including immunotherapy. By targeting autophagy and TNF signaling pathways, MHC-I-deficient tumor cells can be sensitized to T cell-mediated apoptosis. Antigens from apoptotic MHC-I-deficient tumor cells can be efficiently cross-presented by dendritic cells, leading to increased infiltration of T cells producing IFN-γ and TNF-α. Targeting both pathways enables T cell-mediated elimination of tumors with a substantial population of resistant, MHC-I-deficient cells.

CANCER DISCOVERY (2023)

暂无数据